@article{4e6a98b7c14b46dfb7286bcc453e8811,
title = "Myelodysplastic syndromes, version 2.2017: Clinical practice guidelines in oncology",
abstract = "The myelodysplastic syndromes (MDS) comprise a heterogenous group of myeloid disorders with a highly variable disease course. Diagnostic criteria to better stratify patients with MDS continue to evolve, based on morphology, cytogenetics, and the presence of cytopenias. More accurate classification of patients will allow for better treatment guidance. Treatment encompasses supportive care, treatment of anemia, lowintensity therapy, and high-intensity therapy. This portion of the guidelines focuses on diagnostic classification, molecular abnormalities, therapeutic options, and recommended treatment approaches.",
author = "Greenberg, {Peter L.} and Stone, {Richard M.} and Aref Al-Kali and Barta, {Stefan K.} and Rafael Bejar and Bennett, {John M.} and Hetty Carraway and {De Castro}, {Carlos M.} and Deeg, {H. Joachim} and DeZern, {Amy E.} and Fathi, {Amir T.} and Olga Frankfurt and Karin Gaensler and Guillermo Garcia-Manero and Griffiths, {Elizabeth A.} and David Head and Ruth Horsfall and Johnson, {Robert A.} and Mark Juckett and Klimek, {Virginia M.} and Rami Komrokji and Kujawski, {Lisa A.} and Maness, {Lori J.} and O'Donnell, {Margaret R.} and Pollyea, {Daniel A.} and Shami, {Paul J.} and Stein, {Brady L.} and Walker, {Alison R.} and Peter Westervelt and Amer Zeidan and Shead, {Dorothy A.} and Courtney Smith",
note = "Publisher Copyright: {\textcopyright} JNCCN-Journal of the National Comprehensive Cancer Network.",
year = "2017",
month = jan,
day = "1",
doi = "10.6004/jnccn.2017.0007",
language = "English (US)",
volume = "15",
pages = "60--87",
journal = "JNCCN Journal of the National Comprehensive Cancer Network",
issn = "1540-1405",
publisher = "Cold Spring Publishing LLC",
number = "1",
}